These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8537676)

  • 1. Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.
    Harb GE; Mandema JW; Delahunty T; Benowitz NB; Coleman R; Sheiner LB; Jacobson MA
    J Infect Dis; 1996 Jan; 173(1):273. PubMed ID: 8537676
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antiretroviral therapy in the management of HIV infection in women.
    Mofenson LM
    Clin Obstet Gynecol; 1996 Jun; 39(2):361-85. PubMed ID: 8734002
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
    Stretcher BN
    Clin Pharmacokinet; 1995 Jul; 29(1):46-65. PubMed ID: 7586898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic therapy for human immunodeficiency virus infection: a review.
    Neuzil KM
    Am J Med Sci; 1994 May; 307(5):368-73. PubMed ID: 7513499
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy for human immunodeficiency virus infection -- what have we learned?
    Corey L; Holmes KK
    N Engl J Med; 1996 Oct; 335(15):1142-4. PubMed ID: 8813046
    [No Abstract]   [Full Text] [Related]  

  • 6. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical use of didanosine.
    Kahn J
    Adv Exp Med Biol; 1996; 394():245-56. PubMed ID: 8815689
    [No Abstract]   [Full Text] [Related]  

  • 8. Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.
    Morse GD; Fischl MA; Shelton MJ; Borin MT; Driver MR; DeRemer M; Lee K; Wajszczuk CP
    Antimicrob Agents Chemother; 1996 Mar; 40(3):767-71. PubMed ID: 8851608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between didanosine exposure and surrogate marker response in human immunodeficiency virus-infected outpatients.
    Adams JM; Shelton MJ; Hewitt RG; Grasela TH; DeRemer M; Morse GD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):821-6. PubMed ID: 9559790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons.
    Griffy KG
    AIDS; 1996 Dec; 10 Suppl 4():S3-6. PubMed ID: 9110063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV infection--current possibilities in antiviral therapy].
    Hirschel B
    Ther Umsch; 1994 Aug; 51(8):545-50. PubMed ID: 7940411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in antiretroviral drug therapy for HIV infection.
    Johnson VA
    AIDS Clin Rev; 1992; ():69-104. PubMed ID: 1318738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiretroviral treatment against HIV].
    González-Lahoz J; Soriano V
    Med Clin (Barc); 1995 Sep; 105(10):377-8. PubMed ID: 7475441
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics of nucleoside antiretroviral agents.
    Dudley MN
    J Infect Dis; 1995 Mar; 171 Suppl 2():S99-112. PubMed ID: 7861025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 17. Ups and downs--and ups in the antiviral therapy of HIV infection.
    Weller IV; Williams I
    Genitourin Med; 1996 Feb; 72(1):2-5. PubMed ID: 8655161
    [No Abstract]   [Full Text] [Related]  

  • 18. Continued zidovudine or didanosine for human immunodeficiency virus infection.
    Behrman RE; Kammerman LA; Feigal DW
    N Engl J Med; 1992 Nov; 327(22):1598-9. PubMed ID: 1435893
    [No Abstract]   [Full Text] [Related]  

  • 19. Zalcitabine and didanosine.
    Lipsky JJ
    Lancet; 1993 Jan; 341(8836):30-2. PubMed ID: 8093278
    [No Abstract]   [Full Text] [Related]  

  • 20. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
    Matthews SJ; Cersosimo RJ; Spivack ML
    Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.